Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-435-2
CAS number: 83066-88-0
Full information as given in the memorandum:
Oral administration of 0.4, 2.0, 10.0, 25.0 and 50.0 mg/kg/day to
pregnant rats from 7 days to day 17 of gestation produced no maternal or
foetal effects in a preliminary teratogenicity study.
Remark: In the internal memorandum the dose levels were given as "0.4,
2.0, 10.0, 25.0 and 50.0 mg/g/day". It is assumed that this is due to a
typing error and "mg/g/day" should read as "mg/kg/day". All dose levels
refer to the test substance (i.e. the racemate).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again